Department of Outcomes Research, Cleveland Clinic, Cleveland, Ohio, United States of America.
PLoS One. 2013 May 28;8(5):e63831. doi: 10.1371/journal.pone.0063831. Print 2013.
To determine the effect of vitamin D on postoperative outcomes in cardiac surgical patients.
Retrospective study.
Single institution-teaching hospital.
Adult cardiac surgical patients with perioperative 25-hydroxyvitamin D measurements.
None. We gathered information from the Cardiac Anesthesiology Registry that was obtained at the time of the patients' visit/hospitalization.
We used data of 18,064 patients from the Cardiac Anesthesiology Registry; 426 patients with 25-hydroxyvitamin D measurements met our inclusion criteria. Association with Vitamin D concentration and composite of 11 cardiac morbidities was done by multivariate (i.e., multiple outcomes per subject) analysis. For other outcomes separate multivariable logistic regressions and adjusting for the potential confounders was used. The observed median vitamin D concentration was 19 [Q1-Q3∶12, 30] ng/mL. Vitamin D concentration was not associated with our primary composite of serious cardiac morbidities (odds ratio [OR], 0.96; 95% CI, 0.86-1.07). Vitamin D concentration was also not associated with any of the secondary outcomes: neurologic morbidity (P = 0.27), surgical (P = 0.26) or systemic infections (P = 0.58), 30-day mortality (P = 0.55), or length of initial intensive care unit (ICU) stay (P = 0.04).
Our analysis suggests that perioperative vitamin D concentration is not associated with clinically important outcomes, likely because the outcomes are overwhelmingly determined by other baseline and surgical factors.
确定维生素 D 对心脏外科患者术后结局的影响。
回顾性研究。
单机构教学医院。
接受过围手术期 25-羟维生素 D 测量的成年心脏外科患者。
无。我们从心脏麻醉登记处收集信息,这些信息是在患者就诊/住院时获得的。
我们使用了心脏麻醉登记处的 18064 名患者的数据;有 25-羟维生素 D 测量值的 426 名患者符合我们的纳入标准。通过多变量(即每个受试者多个结果)分析,将维生素 D 浓度与 11 种心脏合并症的复合指标进行了关联。对于其他结果,单独使用多变量逻辑回归,并对潜在混杂因素进行了调整。观察到的中位维生素 D 浓度为 19 [Q1-Q3∶12, 30] ng/mL。维生素 D 浓度与我们的主要严重心脏合并症复合指标(比值比 [OR],0.96;95%置信区间,0.86-1.07)无关。维生素 D 浓度与神经系统合并症(P=0.27)、手术(P=0.26)或全身感染(P=0.58)、30 天死亡率(P=0.55)或初始重症监护病房(ICU)入住时间(P=0.04)的任何次要结局也无关。
我们的分析表明,围手术期维生素 D 浓度与临床重要结局无关,可能是因为这些结局主要由其他基线和手术因素决定。